Rodriguez, Alfredo E <br/><br/>
Emerging drugs for coronary restenosis: the role of systemic oral agents the in stent era.  [electronic resource] 

 -  Expert opinion on emerging drugs  Dec 2009 
 - 561-76 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7623 
<br/><br/><label>Standard No.: </label>10.1517/14728210903203808  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angioplasty, Balloon, Coronary<br/>Antineoplastic Agents, Phytogenic<br/>Coated Materials, Biocompatible<br/>Coronary Angiography--methods<br/>Coronary Restenosis--etiology<br/>Coronary Thrombosis--prevention & control<br/>Drug-Eluting Stents--trends<br/>Electrocardiography<br/>Graft Occlusion, Vascular--prevention & control<br/>Humans<br/>Immunosuppressive Agents--therapeutic use<br/>Meta-Analysis as Topic<br/>Myocardial Infarction--prevention & control<br/>Platelet Aggregation Inhibitors--adverse effects<br/>Prosthesis Design<br/>Registries<br/>Sirolimus--adverse effects<br/>Stents--adverse effects<br/>Treatment Outcome<br/>Tubulin Modulators--therapeutic use